Mon, June 26, 2023
Fri, June 23, 2023
Thu, June 22, 2023
Wed, June 21, 2023
Tue, June 20, 2023
Mon, June 19, 2023
Fri, June 16, 2023

Charles Duncan Reiterated (AXSM) at Buy and Held Target at $104 on, Jun 22nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-104-on-jun-22nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $104 on, Jun 22nd, 2023.

Charles has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Charles


  • Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Thursday, June 15th, 2023
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $95 on, Wednesday, June 14th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 11th, 2023

Publication Contributing Sources